• Home
  • Search Results

Search Results

2808 studies match your search
Open

Peanut Allergy Study for Children and Adolescents

The research study is testing a new study treatment for peanut allergy. The new study treatment is called PVX108. The study doctor and the study sponsor want to learn more about this study drug and to see if it is safe and helpful for children who are allergic to peanuts. The study drug has been used safely in adults and teenagers with peanut allergy. This will be the first time that the study drug will be tested on children in this age group.

Age & Gender
  • 4 years ~ 11 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
Not currently enrolling

Arabic Reading Study for non-native readers

In this study, we want to learn if there is a relationship between proficiency in a language and how a person reads and depends on certain word structure cues.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Eyes and Vision
  • Language and Speech
Open

Effects of IRF Deployment on Academic and Emotional Wellbeing of Military Children

Did your spouse or partner deploy with the 82nd Airborne during an IRF activation? Were any of your children in grades K-12 during that time? If so, we would like to hear from you about your experiences! Your voice matters.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Opinions and Perceptions
  • Veteran Health / Military
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Open

SPECT-CT Guided Elective Contralateral Neck Treatment for Pts With Lateralized Oropharyngeal Cancer

Have you been diagnosed with Lateralized Oropharyngeal Cancer . If so, you may be able to take part in a research study looking at the safety by using a special imaging study called lymph node mapping (lymphatic mapping) Single Photon Emission Computed Tomography (SPECT-CT) compared to the usual treatment when radiotherapy is given .

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Head and Neck)
Coming Soon

Reduced Dose of Cyclophosphamide to Prevent Graft versus Host Disease after Stem Cell Transplant

Cyclophosphamide is a chemotherapy (chemo) drug often given after a transplant to prevent GvHD. We are doing this study to see if a lower dose of cyclophosphamide after transplant is safer, but just as effective. Cyclophosphamide can prevent GvHD, but it can also make you sick and more likely to get an infection. This study will look at how well a lower dose of cyclophosphamide works to reduce these side effects, while also preventing GvHD. This study does not include any new or untested drugs. The drugs and procedures in this study are standard for transplant.

Age & Gender
  • 18 years ~ 65 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia, Lymphoma)
  • Transplant
Not currently enrolling

Geriatric Functional Assessment System Using Passive Wearable Sensing and Deep Learning

We are testing out a device that collects physical function data among older adults who have multiple chronic conditions. We want to see if the device works efficiently and is user friendly.

Age & Gender
  • 65 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
Open

EFFEKTOR Study for Kidney Transplant Recipents

The study treatment, finerenone, is being developed to help people who have long lasting kidney disease, also known as chronic kidney disease (CKD). It works by blocking a certain hormone called aldosterone that causes injury and inflammation in the heart and kidney which is known to play a role in CKD. In this study, the researchers want to learn if finerenone works the same way in kidney transplant recipients. Some subjects will receive the study drug and some will receive a placebo.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Coming Soon

A Comparator Study of a Tasso device to traditional venous blood sampling methods for CBC in patients with leukemia, lymphoma, or other blood cell disorders

This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Leukemia, Lymphoma)
Not currently enrolling

Stigma Reduction and HIV Prevention among Young Latino Sexual Minority Men

In this study, we want to better understand how experiences of stigma and discrimination affect HIV testing and PrEP use among young Latino sexual minority men.

Age & Gender
  • 18 years ~ 24 years
  • Male
Study Interest
  • HIV/AIDS
  • Mental and Emotional Health
  • Opinions and Perceptions
  • and 6 more
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

Online Experience Interview

Through in-person and remote, hour-long interviews, this research study aims to understand how the how young people in the United States experience social media.

Age & Gender
  • 18 years ~ 23 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Opinions and Perceptions
  • Social or Workplace Dynamics
  • and 3 more
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research